News · 18 November 2026

Chinese drug more than doubles time before breast cancer grows

18 November 2026 · Health · Science · Uplifting

Chinese drug more than doubles time before breast cancer grows
Picture: MedPage Today · MedPage Today lead image · unknown

A Chinese cancer drug more than doubled the time before breast cancer got worse, a trial found. The drug is called trastuzumab rezetecan. Patients on it went a median 16.4 months before their cancer grew, against 6.8 months on chemotherapy. The trial had 551 patients in China with HER2-low breast cancer. Serious side effects were more common on the drug.

Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.

Also on 18 November 2026